Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.
Fibrosis
Pulmonology
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
10 Jan 2019
10 Jan 2019
Historique:
received:
01
10
2018
accepted:
20
11
2018
pubmed:
11
1
2019
medline:
11
1
2019
entrez:
11
1
2019
Statut:
epublish
Résumé
The extracellular matrix (ECM) in idiopathic pulmonary fibrosis (IPF) drives fibrosis progression; however, the ECM composition of the fibroblastic focus (the hallmark lesion in IPF) and adjacent regions remains incompletely defined. Herein, we serially sectioned IPF lung specimens constructed into tissue microarrays and immunostained for ECM components reported to be deregulated in IPF. Immunostained sections were imaged, anatomically aligned, and 3D reconstructed. The myofibroblast core of the fibroblastic focus (defined by collagen I, α-smooth muscle actin, and procollagen I immunoreactivity) was associated with collagens III, IV, V, and VI; fibronectin; hyaluronan; and versican immunoreactivity. Hyaluronan immunoreactivity was also present at the fibroblastic focus perimeter and at sites where early lesions appear to be forming. Fibrinogen immunoreactivity was often observed at regions of damaged epithelium lining the airspace and the perimeter of the myofibroblast core but was absent from the myofibroblast core itself. The ECM components of the fibroblastic focus were distributed in a characteristic and reproducible manner in multiple patients. This information can inform the development of high-fidelity model systems to dissect mechanisms by which the IPF ECM drives fibrosis progression.
Identifiants
pubmed: 30626754
pii: 125185
doi: 10.1172/jci.insight.125185
pmc: PMC6485370
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL146501
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007741
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL091775
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL125236
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL125227
Pays : United States
Références
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):631-6
pubmed: 9279250
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6642-6
pubmed: 1862087
Matrix Biol. 2019 May;78-79:60-83
pubmed: 29362135
Hum Pathol. 1995 Jan;26(1):53-61
pubmed: 7529742
J Histochem Cytochem. 2006 Dec;54(12):1315-25
pubmed: 16924125
Stem Cells. 2006 Apr;24(4):928-35
pubmed: 16306150
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Lancet Respir Med. 2018 Feb;6(2):138-153
pubmed: 29154106
Histochem Cell Biol. 2013 Jun;139(6):759-83
pubmed: 23652571
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263297
J Clin Invest. 2014 Apr;124(4):1622-35
pubmed: 24590289
Am Rev Respir Dis. 1989 Dec;140(6):1693-703
pubmed: 2604297
Nat Rev Mol Cell Biol. 2009 Aug;10(8):538-49
pubmed: 19603038
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1203-8
pubmed: 14754760
Int J Clin Exp Pathol. 2012;5(1):58-71
pubmed: 22295148
Am J Respir Crit Care Med. 2018 Aug 15;198(4):486-496
pubmed: 29579397
J Clin Invest. 2017 Jun 30;127(7):2586-2597
pubmed: 28530639
Am Rev Respir Dis. 1985 Feb;131(2):281-9
pubmed: 3882034
Am J Pathol. 2005 Aug;167(2):365-79
pubmed: 16049324
J Proteome Res. 2011 May 6;10(5):2185-205
pubmed: 21319792
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626754
Br J Cancer. 2004 Feb 9;90(3):561-5
pubmed: 14760364
J Thromb Haemost. 2009 Jul;7 Suppl 1:151-4
pubmed: 19630789
Oncotarget. 2017 Sep 8;8(55):93729-93740
pubmed: 29212185
Cancer Res. 2016 May 1;76(9):2507-12
pubmed: 27197262
Mol Diagn Ther. 2015 Oct;19(5):299-308
pubmed: 26232909
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Hum Pathol. 2009 Aug;40(8):1182-8
pubmed: 19368952
Int J Cancer. 1989 Sep 15;44(3):445-8
pubmed: 2550372
J Dermatol Sci. 2013 Mar;69(3):187-94
pubmed: 23340440
Matrix. 1993 Nov;13(6):447-55
pubmed: 8309424
Am J Respir Crit Care Med. 2012 Nov 1;186(9):866-76
pubmed: 22936357
Cancer. 2014 Jun 15;120(12):1800-9
pubmed: 24668563
Am J Pathol. 1991 May;138(5):1257-65
pubmed: 2024710
Am J Respir Crit Care Med. 2008 Nov 1;178(9):939-47
pubmed: 18703791
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L127-L136
pubmed: 28860143
Sci Rep. 2017 Nov 15;7(1):15671
pubmed: 29142263
Arch Dermatol. 2007 Feb;143(2):155-63
pubmed: 17309996
Am J Pathol. 1996 Oct;149(4):1241-56
pubmed: 8863673
Am J Respir Crit Care Med. 1995 Jun;151(6):1956-64
pubmed: 7767545
J Proteomics. 2013 Jun 24;85:109-28
pubmed: 23659799
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1819-28
pubmed: 8970376
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1298-1310
pubmed: 28654764
J Clin Invest. 2018 Jan 2;128(1):45-53
pubmed: 29293088
PLoS One. 2013 Oct 21;8(10):e76451
pubmed: 24204629